<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03573026402969</udiDi>
    <basicUdiDi>357302BUDI000346TH</basicUdiDi>
    <tradeName>VIDAS® CMV IgG Avidity II</tradeName>
    <deviceName>VIDAS® CMV IgG Avidity II</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>413557</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:51:42.143Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056771100915</udiDi>
    <basicUdiDi>80567713107654V</basicUdiDi>
    <tradeName>LIAISON® CMV IgG Avidity II</tradeName>
    <deviceName>LIAISON® CMV IgG Avidity II</deviceName>
    <manufacturerName>DiaSorin Italia S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000029422</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>310765</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-22T22:39:15.038Z</lastUpdated>
  </row>
  <row>
    <udiDi>08054320950080</udiDi>
    <basicUdiDi>805432095ISID5501MF</basicUdiDi>
    <tradeName>08054320950080</tradeName>
    <deviceName>IDS CMV IgG Avidity</deviceName>
    <manufacturerName>Technogenetics S.p.A</manufacturerName>
    <manufacturerSrn>IT-MF-000025331</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>IS-ID5501</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:43:07.792Z</lastUpdated>
  </row>
  <row>
    <udiDi>+ENTIEIA-59640C</udiDi>
    <basicUdiDi>B-+ENTIEIA-59640C</basicUdiDi>
    <tradeName>+ENTIEIA-59640C</tradeName>
    <deviceName>Avidity Cytomegalovirus (CMV) IgG ELISA</deviceName>
    <manufacturerName>Gold Standard Diagnostics Frankfurt GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000025020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EIA-5964</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T10:13:49.267Z</lastUpdated>
  </row>
  <row>
    <udiDi>+ENTIACMV71100.</udiDi>
    <basicUdiDi>B-+ENTIACMV71100.</basicUdiDi>
    <tradeName>+ENTIACMV71100.</tradeName>
    <deviceName>NovaLisa® Avidity Cytomegalovirus (CMV) IgG</deviceName>
    <manufacturerName>Gold Standard Diagnostics Frankfurt GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000025020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ACMV7110</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T10:08:31.803Z</lastUpdated>
  </row>
  <row>
    <udiDi>38594036041333</udiDi>
    <basicUdiDi>B-38594036041333</basicUdiDi>
    <tradeName>MONO-VIDITEST anti-CMV IgG avidity</tradeName>
    <deviceName></deviceName>
    <manufacturerName>VIDIA spol. s r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000036964</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>KZ-133-12</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-11T15:53:58.219Z</lastUpdated>
  </row>
  <row>
    <udiDi>28594036041770</udiDi>
    <basicUdiDi>B-28594036041770</basicUdiDi>
    <tradeName>ELISA-VIDITEST anti-CMV IgG and IgG avidity</tradeName>
    <deviceName></deviceName>
    <manufacturerName>VIDIA spol. s r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000036964</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ODZ-177</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-11T13:21:11.937Z</lastUpdated>
  </row>
  <row>
    <udiDi>18594036041339</udiDi>
    <basicUdiDi>B-18594036041339</basicUdiDi>
    <tradeName>MONO-VIDITEST anti-CMV IgG avidita</tradeName>
    <deviceName></deviceName>
    <manufacturerName>VIDIA spol. s r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000036964</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>K-133-12</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-11T07:25:00.109Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594036041059</udiDi>
    <basicUdiDi>B-08594036041059</basicUdiDi>
    <tradeName>ELISA-VIDITEST anti-CMV IgG a avidita IgG</tradeName>
    <deviceName></deviceName>
    <manufacturerName>VIDIA spol. s r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000036964</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0105040206</emdnCode>
    <emdnDescription>CMV IGG - AVIDITY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>OD-105</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:43:13.733Z</lastUpdated>
  </row>
</eudamedExport>